Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for treatment of leishmaniasis
IRCT20251211068289N2Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in leishmaniasis, sponsored by Isfahan University of Medical Sciences. Started Dec 2025; status: recruiting.
02
Drugs
pentoxifylline
03
Conditions
leishmaniasis
Beyond the preview
Go deeper on IRCT20251211068289N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251211068289N2.